Simcere Pharmaceuticals Group’s Strategic Collaboration on Multiple Bispecific Antibodies

Ropes & Gray advised Simcere Pharmaceutical Group in a strategic collaboration with Netherlands-based Merus to obtain an exclusive license to develop and commercialize in China three…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

GIC’s Partnership with Citco

McCormick’s $2 Billion Revolving Credit Facility

Domos’ Series Seed Funding

Caixa Econômica Federal’s EMTN Programme and $700 Million Social Bond Offering

Empresa Distribuidora de Electricidad de Mendoza’s US$24 Million Notes Issuance

Camarero Uno’s Sale of 40% Stake in Bronx 23 SpA

Altano Group’s Acquisition of Tampereen Hevosklinikka

Merlett Tecnoplastic S.p.A. (Continental)’s Board of Statutory Auditors

Endomines’ Financing Arrangement

AD Ports Group’s 50-Year Usufruct Agreement with SCZONE

Bidvest Group’s Acquisition of Citron Hygiene

Tasaheel’s EGP 2.5 Billion Bond Issuance

Uber’s $700 Million Acquisition Of Trendyol Go

Seesaw’s Acquisition of Little Thinking Minds

Sunset Hospitality Group’s Investment Round

EAAA India Alternatives Limited’s Structured Debt Financing

Laopu Gold Co., Ltd.’s HK$2.7 Billion Shares Placement on HKEX

UK’s National Wealth Fund’s £600 Million Facility For ScottishPower

Sheppard Mullin Welcomes New Chief Information Officer David Lampert

Fieldfisher Launches its Second One Firm Action Campaign to Create Charitable Impact Across its International Network

Pierson Ferdinand Forms Latin America Practice

Foley Expands East Coast Litigation Bench, Adds Three Partners in New York and Raleigh

Li Zhu Rejoins Quarles Intellectual Property Team in Washington Office as Partner

SouzaOkawa Announces New Partner: Jaili Cunha

Simcere Pharmaceuticals Group’s Strategic Collaboration on Multiple Bispecific Antibodies

Standard 1 Year Membership Required

Author: Michael Patrini

Standard 1 Year Membership Required